CAFC Affirms JMOL of Non-Infringement in Blood Sequestration Device Patent Dispute
By Editorial Team
The U.S. Court of Appeals for the Federal Circuit (CAFC) has upheld a district court’s judgment of no infringement in a patent dispute involving blood sequestration devices. The case, Magnolia Medical Technologies, Inc. v. Kurin, Inc., revolved around patents held by Magnolia Medical Technologies, Inc. related to devices that enhance the accuracy of blood tests. The dispute focused on whether Kurin, Inc.’s Kurin Lock product infringed U.S. Patent Nos. 10,039,483 and 9,855,001.
In the lawsuit, Magnolia alleged that Kurin’s product infringed its patents by failing to meet the structural requirements outlined in the claims. Specifically, the dispute centered on whether the accused product utilized separate corresponding structures for the limitations listed in the claims. The district court ruled in favor of Kurin, finding that the accused product did not infringe as a matter of law because it did not contain distinct structures for each limitation as required by the patent claims.
During the proceedings, the parties debated the construction of certain claim terms, with the district court ultimately determining that the accused product did not meet the structural requirements set forth in the patent claims. Following this decision, Kurin moved for a judgment as a matter of law, which the district court granted, leading to Magnolia’s appeal to the CAFC.
In its decision, the CAFC affirmed the district court’s ruling, stating that the plain and ordinary meaning of the claims required separate corresponding structures for each limitation. The court emphasized that when claim limitations are listed separately, it implies that they are distinct components of the patented invention. Additionally, the CAFC rejected Magnolia’s arguments regarding claim differentiation, noting that dependent claims do not necessarily have to be broader than the independent claims on which they depend.
Ultimately, the CAFC upheld the district court’s judgment of no infringement for the ‘483 patent and affirmed the court’s construction of the ‘001 patent. The decision serves as a reminder of the importance of closely analyzing claim language and corresponding structures in patent disputes.
